Rothschild Investment LLC’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-70
| Closed | -$55 | – | 3076 |
|
|
2025
Q1 | $55 | Hold |
70
| – | – | ﹤0.01% | 2997 |
|
|
2024
Q4 | $116 | Buy |
70
+30
| +75% | +$50 | ﹤0.01% | 2889 |
|
|
2024
Q3 | $140 | Buy |
40
+5
| +14% | +$18 | ﹤0.01% | 2781 |
|
|
2024
Q2 | $115 | Buy |
+35
| New | +$115 | ﹤0.01% | 2695 |
|
|
2023
Q1 | – | Sell |
-15,600
| Closed | -$157K | – | 490 |
|
|
2022
Q4 | $157K | Sell |
15,600
-1,650
| -10% | -$16.6K | 0.01% | 448 |
|
|
2022
Q3 | $387K | Buy |
+17,250
| New | +$387K | 0.04% | 314 |
|